Mapping the Neural Circuits of Depression and Anxiety Using Personalized, Accelerated TMS and Deep Phenotyping

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21-70
SponsorNational University Hospital, Singapore

About this trial

This proposal seeks to carry out a double-blinded, randomized, comparative study that investigates neurobehavioral changes induced by personalized, anxiosomatic and dysphoric network guided accelerated intermittent-theta burst (iTBS) using dense functional Magnetic Resonance Imaging (fMRI) sampling in participants with treatment-resistant depression (TRD) and moderate/high levels of anxiety.

Eligibility criteria

Qualifiers

Male/female aged 21-70

Diagnosis of MDD as validated by MINI

Non-response to adequate trial (4 weeks) of at least two MDD medication as verified by the study clinician

BDI score of 20 or above; BAI score of 16 or above

Disqualifiers

DSM-5 psychotic disorder

Drug or alcohol abuse or dependence (preceding 3 months)

Rapid clinical response required, e.g., high suicide risk

Significant neurological disorder, which may pose increased risks with TMS, e.g., epilepsy

Trial design

Treatments tested in this trial

  • Individualized connectome-guided accelerated iTBS

Treatment groups

36 Participants
are divided into 2 treatment groups

Sponsors and collaborators

National University Hospital, Singapore

Lead sponsor

National University of Singapore

Collaborator